BR0311180A - Métodos para o tratamento de doenças e condições respiratórias utilizando um inibidor seletivo da inos - Google Patents
Métodos para o tratamento de doenças e condições respiratórias utilizando um inibidor seletivo da inosInfo
- Publication number
- BR0311180A BR0311180A BR0311180-6A BR0311180A BR0311180A BR 0311180 A BR0311180 A BR 0311180A BR 0311180 A BR0311180 A BR 0311180A BR 0311180 A BR0311180 A BR 0311180A
- Authority
- BR
- Brazil
- Prior art keywords
- methods
- conditions
- respiratory diseases
- inos
- selective inhibitor
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 3
- 208000023504 respiratory system disease Diseases 0.000 title abstract 2
- 101100396994 Drosophila melanogaster Inos gene Proteins 0.000 title 1
- 229940124639 Selective inhibitor Drugs 0.000 title 1
- 201000010099 disease Diseases 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 230000000241 respiratory effect Effects 0.000 abstract 2
- 101000998969 Homo sapiens Inositol-3-phosphate synthase 1 Proteins 0.000 abstract 1
- 102100036881 Inositol-3-phosphate synthase 1 Human genes 0.000 abstract 1
- 229940123134 Nitric oxide inhibitor Drugs 0.000 abstract 1
- 230000001939 inductive effect Effects 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Immunology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
"MéTODOS PARA O TRATAMENTO DE DOENçAS E CONDIçõES RESPIRATóRIAS UTILIZANDO UM INIBIDOR SELETIVO DA INOS". A presente invenção refere-se a métodos terapêuticos para a prevenção e tratamento de doenças ou condições respiratórias, incluindo os métodos a administração a um paciente necessitado daqueles de uma quantidade eficaz para a doença ou condição respiratória de um inibidor seletivo da óxido nítricosintase indutível.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US38105402P | 2002-05-16 | 2002-05-16 | |
PCT/US2003/015369 WO2003097163A2 (en) | 2002-05-16 | 2003-05-16 | Using a selective inos inhibitor for the treatment of respiratory diseases and conditions |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0311180A true BR0311180A (pt) | 2005-03-01 |
Family
ID=29550060
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0311180-6A BR0311180A (pt) | 2002-05-16 | 2003-05-16 | Métodos para o tratamento de doenças e condições respiratórias utilizando um inibidor seletivo da inos |
Country Status (13)
Country | Link |
---|---|
US (1) | US20040077639A1 (pt) |
EP (1) | EP1506040A2 (pt) |
JP (1) | JP2005536467A (pt) |
KR (1) | KR20050004155A (pt) |
CN (1) | CN1652843A (pt) |
AU (1) | AU2003234606A1 (pt) |
BR (1) | BR0311180A (pt) |
CA (1) | CA2486061A1 (pt) |
IL (1) | IL164826A0 (pt) |
MX (1) | MXPA04011404A (pt) |
PL (1) | PL373952A1 (pt) |
WO (1) | WO2003097163A2 (pt) |
ZA (1) | ZA200408905B (pt) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004080954A1 (en) * | 2003-03-11 | 2004-09-23 | Pharmacia Corporation | S-[2-[(1-iminoethyl)amino]ethyl]-2-methyl-l-cysteine maleate form ii crystalline salt |
WO2004080953A1 (en) * | 2003-03-11 | 2004-09-23 | Pharmacia Corporation | S-[2-[(1-iminoethyl)amino]ethyl]-2-methyl-l-cysteine salicylate monohydrate crystalline salt |
AU2005274765B2 (en) * | 2004-07-23 | 2012-08-30 | Arjil Pharmaceuticals Llc | Anti-hypersensitive inflammation and anti-allergy activities of Zingiber zerumbet (L.) Smith |
TWI375671B (en) * | 2010-03-01 | 2012-11-01 | Univ China Medical | Pharmaceutical compositions containing brazilin for inhibiting expression of cytokines of t helper cell type ii and/or inhibiting expression of chemokines and uses of the same |
EP2591777B1 (de) * | 2010-07-09 | 2016-12-14 | Justus-Liebig-Universität Gießen | L-NIL als Inhibitor zur Regeneration der Lunge von an COPD leidenden Patienten |
US11834430B2 (en) | 2017-09-12 | 2023-12-05 | Agency For Science, Technology And Research | Compounds useful as inhibitors of isoprenylcysteine carboxyl methyltransferase |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6262784B1 (en) * | 1993-06-01 | 2001-07-17 | Samsung Electronics Co., Ltd | Active matrix display devices having improved opening and contrast ratios and methods of forming same and a storage electrode line |
US5824669A (en) * | 1996-03-22 | 1998-10-20 | Nitromed, Inc. | Nitrosated and nitrosylated compounds and compositions and their use for treating respiratory disorders |
US6331543B1 (en) * | 1996-11-01 | 2001-12-18 | Nitromed, Inc. | Nitrosated and nitrosylated phosphodiesterase inhibitors, compositions and methods of use |
AU6823098A (en) * | 1997-02-28 | 1998-09-18 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Synergistic combination of pde inhibitors and adenylate cyclase agonists or guanyl cyclyse agonists |
GB9811599D0 (en) * | 1998-05-30 | 1998-07-29 | Glaxo Group Ltd | Nitric oxide synthase inhibitors |
DE60116067T2 (de) * | 2000-03-24 | 2006-08-31 | Pharmacia Corp., Chicago | Amidino-verbindungen als hemmstoffe der stickstoffmonoxid-synthase |
US6545170B2 (en) * | 2000-04-13 | 2003-04-08 | Pharmacia Corporation | 2-amino-5, 6 heptenoic acid derivatives useful as nitric oxide synthase inhibitors |
AR032318A1 (es) * | 2000-04-13 | 2003-11-05 | Pharmacia Corp | Compuesto derivado halogenado del acido 2-amino-5,6 heptenoico; composicion farmaceutica que lo comprende y su uso en la fabricacion de un medicamento util como inhibidor de la oxido nitrico sintetasa |
EA005817B1 (ru) * | 2000-08-01 | 2005-06-30 | Фармасиа Корпорейшн | Производные гексагидро-7-1h-азепин-2-илгексановой (или гексеновой) кислоты в качестве ингибиторов индуцибельной синтазы оксида азота |
TWI290130B (en) * | 2000-09-15 | 2007-11-21 | Pharmacia Corp | 2-Amino-2alkyl-5 heptenoic and heptynoic acid derivatives useful as nitric oxide synthase inhibitors |
AR035585A1 (es) * | 2000-09-15 | 2004-06-16 | Pharmacia Corp | Derivados del acido 2-amino-2-alquil-4-heptenoico, composicion farmaceutica y su uso en la fabricacion de medicamentos |
AR031609A1 (es) * | 2000-09-15 | 2003-09-24 | Pharmacia Corp | Derivados de acido 2-amino-2-alquil-3 heptenoico y heptinoico utiles como inhibidores de oxido nitrico sintetasa |
-
2003
- 2003-05-16 US US10/439,669 patent/US20040077639A1/en not_active Abandoned
- 2003-05-16 PL PL03373952A patent/PL373952A1/xx not_active Application Discontinuation
- 2003-05-16 KR KR10-2004-7018523A patent/KR20050004155A/ko not_active Application Discontinuation
- 2003-05-16 JP JP2004505156A patent/JP2005536467A/ja not_active Abandoned
- 2003-05-16 WO PCT/US2003/015369 patent/WO2003097163A2/en active Application Filing
- 2003-05-16 AU AU2003234606A patent/AU2003234606A1/en not_active Abandoned
- 2003-05-16 MX MXPA04011404A patent/MXPA04011404A/es not_active Application Discontinuation
- 2003-05-16 EP EP03728948A patent/EP1506040A2/en not_active Withdrawn
- 2003-05-16 CA CA002486061A patent/CA2486061A1/en not_active Abandoned
- 2003-05-16 CN CNA038111969A patent/CN1652843A/zh active Pending
- 2003-05-16 IL IL16482603A patent/IL164826A0/xx unknown
- 2003-05-16 BR BR0311180-6A patent/BR0311180A/pt not_active IP Right Cessation
-
2004
- 2004-11-03 ZA ZA200408905A patent/ZA200408905B/en unknown
Also Published As
Publication number | Publication date |
---|---|
WO2003097163A2 (en) | 2003-11-27 |
EP1506040A2 (en) | 2005-02-16 |
IL164826A0 (en) | 2005-12-18 |
KR20050004155A (ko) | 2005-01-12 |
JP2005536467A (ja) | 2005-12-02 |
ZA200408905B (en) | 2006-06-28 |
WO2003097163A3 (en) | 2004-10-21 |
PL373952A1 (en) | 2005-09-19 |
CN1652843A (zh) | 2005-08-10 |
CA2486061A1 (en) | 2003-11-27 |
MXPA04011404A (es) | 2005-02-14 |
US20040077639A1 (en) | 2004-04-22 |
AU2003234606A1 (en) | 2003-12-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE457166T1 (de) | Orale zusammensetzungen zur behandlung von diabetes | |
BR0309280A (pt) | Terapia de combinação para o tratamento de câncer | |
WO2004001383A3 (en) | Safe and effective nutritional supplement formulatins and associated regimens adapted to prevent and/or treat targeted diseases or medical or health conditions, and related methods | |
BR0317747A (pt) | Método de tratamento terapêutico concomitante de um indivìduo, composição farmacêutica, kit, uso de um primeiro agente e um segundo agente, e, métodos de prevenir ou tratar uma doença relacionada com amilóide-b, doença de alzheimer e insuficiência cognitiva suave | |
KR960703009A (ko) | 중추유래의 수면성 무호흡증 및 호흡곤란증의 치료를 위한 모다피닐의 사용 | |
DE69921650D1 (de) | Patientenspezifische dosimetrie | |
BR0316685A (pt) | Composições e métodos para a administração aperfeiçoada por via mucosal de peptìdeos fixadores ao receptor de y2 e métodos para tratar e prevenir a obesidade | |
BR0213540A (pt) | Compostos, método para o tratamento de enfermidades ou distúrbios em um paciente e composição farmacêutica que compreende os mesmos | |
BR0116370A (pt) | Composto, composição farmacêutica, uso de um composto, e, método de tratamento de uma doença ou condição mediada por hppar em um paciente. | |
BR9813524A (pt) | Processos para tratamento de toxicidades associadas com a administração de um agente terapêutico a um mamìfero, para tratamento de toxicidades associadas com a exposição de um mamìfero à terapia de radiação, para tratamento de neuro- ou nefrodistúrbios em um humano, e, para tratamento de distúrbios e sintomas clìnicos associados com diabetes do tipo i ou do tipo ii em um humano | |
DE602005010213D1 (de) | Verfahren zur behandlung und diagnose von atemstörungen im schlaf mit zonisamid und mittel zur durchführung des verfahrens | |
BR0111591A (pt) | Compostos, composição farmacêutica, e, métodos para elevar o nìvel de plasma do hormÈnio de crescimento em um mamìfero, para o tratamento de deficiência da secreção do hormÈnio de crescimento, para o tratamento do retardo do crescimento em crianças, para o tratamento de distúrbios metabólicos associados com a deficiência da secreção do hormÈnio de crescimento, em particular em pacientes idosos, e para promover a cura de ferimentos, recupeção de cirurgia ou recuperação de doenças debilitantes | |
MX9100042A (es) | Reduccion o prevencion de irritacion de la piel por drogas | |
BR0310061A (pt) | Métodos para o tratamento de doenças e condições respiratórias com um inibidor seletivo da inos e um inibidor da pde e suas composições | |
BR0315573A (pt) | Método para tratar, prevenir, controlar e/ou modificar dor em um paciente e composição farmacêutica | |
FR2712811B1 (fr) | Procédé pour lutter contre l'adiposite et compositions utilisables à cet effet. | |
BR0313413A (pt) | Uso da vacinação beta amilóide juntamente com um inibidor da cox-2 seletivo para o tratamento da doença de alzheimer | |
WO2003011327A3 (en) | Secretin for the treatment of asthma | |
DE60111025D1 (de) | Verwendung von Topiramat zur Behandlung und Diagnostizierung von Atemstörungen während des Schlafens und Mittel zur Durchführung der Behandlung und Diagnose | |
BR0314713A (pt) | Processos e reagentes para o tratamento de doenças e distúrbios associados com nìveis aumentados de citocinas pró-inflamatórias | |
BR0212989A (pt) | Métodos para tratamento neuroprotetor usando inibidores de inos seletivos | |
WO2003057162A3 (en) | Combination for the treatment of immunoinflammatory disorders and proliferative skin diseases | |
HUP0204048A2 (hu) | Dezloratadin alkalmazása allergiás és gyulladásos tünetek kezelésére | |
BR0311180A (pt) | Métodos para o tratamento de doenças e condições respiratórias utilizando um inibidor seletivo da inos | |
BR0312929A (pt) | Uso de um composto, e, métodos de tratamento, prevenção ou alìvio de uma doença, distúrbio ou condição de um corpo de animal vivo, e da degeneração macular relacionada com a idade de um corpo de animal vivo |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 6A E 7A ANUIDADES. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2051 DE 27/04/2010. |
|
B15K | Others concerning applications: alteration of classification |
Ipc: A61K 31/198 (2006.01), A61P 11/00 (2006.01), A61P |